Analyst Ratings For Novartis AG (NYSE:NVS)
Today, Novartis AG (NYSE:NVS) stock received an upgrade by Morgan Stanley from Underweight to Overweight.
There are 2 sell ratings, 7 hold ratings, 6 buy ratings on the stock.
The current consensus rating on Novartis AG (NYSE:NVS) is Hold (Score: 2.27) with a consensus target price of $82.27 per share, a potential 2.29% downside.
Some recent analyst ratings include
- 7/26/2017-Morgan Stanley Upgrade from a “Underweight ” rating to a ” Overweight” rating.
- 7/18/2017-Cowen and Company Reiterated Rating of Hold.
- 7/17/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
- 7/5/2017-Credit Suisse Group was Downgraded by analysts at Credit Suisse Group from a “Neutral ” rating to a ” Underperform” rating. They now have a $82.25 price target on the stock.
- 6/22/2017-Leerink Swann Reiterated Rating of Market Perform.
- 6/22/2017-Barclays PLC Upgrade from a “Underweight ” rating to a ” Equal Weight” rating.
- 3/22/2017-Goldman Sachs Group, Inc. (The) Reiterated Rating of Neutral.
Dividend information for Novartis AG (NYSE:NVS)
Novartis AG (NYSE:NVS) pays an annual dividend of Community Ranking: with a yield of 2.73% and an average dividend growth of 3.90% based on a 3 Year Average.
Dividend History for Novartis AG (NYSE:NVS)
- On 1/27/2017 Novartis AG announced a Annual dividend of $2.33 with an ex dividend date of 3/1/2017 which will be payable on 3/3/2017.
- On 2/1/2016 Novartis AG announced a Annual dividend of $2.34 with an ex dividend date of 2/24/2016 which will be payable on 2/26/2016.
- On 2/4/2014 Novartis AG announced a annual dividend of $2.72 3.48% with an ex dividend date of 2/27/2014 which will be payable on 3/11/2014.
- On 2/11/2013 Novartis AG announced a annual dividend of $2.53 3.71% with an ex dividend date of 2/26/2013 which will be payable on 4/5/2013.
Recent Insider Trading Activity For Novartis AG (NYSE:NVS)
Novartis AG (NYSE:NVS) has insider ownership of 0.01% and institutional ownership of 11.30%.
- On 7/5/2017 Bioventures Ltd Novartis, Major Shareholder, bought 266,667 with an average share price of $15.00 per share and the total transaction amounting to $4,000,005.00. View SEC Filing
- On 5/11/2016 Institutes For Biomed Novartis, Major Shareholder, bought 277,777 with an average share price of $18.00 per share and the total transaction amounting to $4,999,986.00. View SEC Filing
- On 2/17/2016 Bioventures Ltd Novartis, Major Shareholder, bought 375,000 with an average share price of $8.00 per share and the total transaction amounting to $3,000,000.00. View SEC Filing
- On 9/22/2014 Bioventures Ltd Novartis, Major Shareholder, bought 325,000 with an average share price of $15.00 per share and the total transaction amounting to $4,875,000.00. View SEC Filing
Recent Trading Activity for Novartis AG (NYSE:NVS)
Shares of Novartis AG closed the previous trading session at 84.20 down -0.09 -0.11% with 1,387,032 shares trading hands.